全文获取类型
收费全文 | 751篇 |
免费 | 54篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 35篇 |
妇产科学 | 8篇 |
基础医学 | 86篇 |
口腔科学 | 11篇 |
临床医学 | 52篇 |
内科学 | 183篇 |
皮肤病学 | 21篇 |
神经病学 | 24篇 |
特种医学 | 145篇 |
外科学 | 68篇 |
综合类 | 22篇 |
一般理论 | 1篇 |
预防医学 | 31篇 |
眼科学 | 9篇 |
药学 | 89篇 |
肿瘤学 | 33篇 |
出版年
2022年 | 3篇 |
2021年 | 8篇 |
2020年 | 3篇 |
2019年 | 6篇 |
2018年 | 8篇 |
2017年 | 2篇 |
2016年 | 10篇 |
2015年 | 19篇 |
2014年 | 15篇 |
2013年 | 17篇 |
2012年 | 21篇 |
2011年 | 37篇 |
2010年 | 28篇 |
2009年 | 35篇 |
2008年 | 27篇 |
2007年 | 40篇 |
2006年 | 34篇 |
2005年 | 39篇 |
2004年 | 35篇 |
2003年 | 25篇 |
2002年 | 26篇 |
2001年 | 25篇 |
2000年 | 18篇 |
1999年 | 15篇 |
1998年 | 25篇 |
1997年 | 41篇 |
1996年 | 26篇 |
1995年 | 26篇 |
1994年 | 20篇 |
1993年 | 6篇 |
1992年 | 11篇 |
1991年 | 5篇 |
1990年 | 15篇 |
1989年 | 15篇 |
1988年 | 9篇 |
1987年 | 15篇 |
1986年 | 10篇 |
1985年 | 11篇 |
1984年 | 7篇 |
1983年 | 10篇 |
1982年 | 8篇 |
1981年 | 10篇 |
1980年 | 12篇 |
1979年 | 4篇 |
1978年 | 7篇 |
1977年 | 8篇 |
1976年 | 9篇 |
1975年 | 6篇 |
1974年 | 3篇 |
1971年 | 2篇 |
排序方式: 共有819条查询结果,搜索用时 15 毫秒
141.
The vomeronasal system (VNS) is an accessory olfactory structure present in most mammals adhibited to the detection of specific chemosignals implied in social and reproductive behavior. The VNS comprises the vomeronasal organ (VNO), vomeronasal nerve and accessory olfactory bulb. VNO is characterized by a neuroepithelium constituted by bipolar neurons and supporting and stem/progenitor cells. In humans, VNO is present during fetal life and is supposed to possess chemoreceptor activity and participate in gonadotropin-releasing hormone neuronal precursor migration toward the hypothalamus. Instead, the existence and functions of VNO in postnatal life is debated. Vascular endothelial growth factor (VEGF) and its receptors (VEGFRs) have been demonstrated to play fundamental roles in various neurogenic events. However, there are no data regarding the localization and possible function of VEGF/VEGFRs in human fetal VNO. Therefore, this study was conceived to investigate the expression of VEGF/VEGFRs in human VNO in an early developmental period (9–12 weeks of gestation), when this organ appears well structured. Coronal sections of maxillofacial specimens were subjected to peroxidase-based immunohistochemistry for VEGF, VEGFR-1 and VEGFR-2. Double immunofluorescence for VEGF, VEGFR-1 or VEGFR-2 and the neuronal marker protein gene product 9.5 (PGP 9.5) was also performed. VEGF expression was evident in the entire VNO epithelium, with particularly strong reactivity in the middle layer. Strongly VEGF-immunostained cells with aspect similar to bipolar neurons and/or their presumable precursors were detected in the middle and basal layers. Cells detaching from the basal epithelial layer and detached cell groups in the surrounding lamina propria showed moderate/strong VEGF expression. The strongest VEGFR-1 and VEGFR-2 expression was detected in the apical epithelial layer. Cells with aspect similar to bipolar neurons and/or their presumable precursors located in the middle and basal layers and the detaching/detached cells displayed a VEGFR-1 and VEGFR-2 reactivity similar to that of VEGF. The basal epithelial layer exhibited stronger staining for VEGFRs than for VEGF. Cells with morphology and VEGF/VEGFR expression similar to those of the detaching/detached cells were also detected in the middle and basal VNO epithelial layers. Double immunofluorescence using anti-PGP 9.5 antibodies demonstrated that most of the VEGF/VEGFR-immunoreactive cells were neuronal cells. Collectively, our findings suggest that during early fetal development the VEGF/VEGFR system might be involved in the presumptive VNO chemoreceptor activity and neuronal precursor migration. 相似文献
142.
INTRODUCTION: Radiation exposure to the radiotherapy staff operating with linear accelerators comes from both normal exposure, which can be easily quantified by direct measurement, and potential exposure, whose evaluation is made difficult by its stochastic character. International guidelines recommend that risk be of the same order of magnitude for both types of exposure. We evaluated the health risk associated with potential exposure following the fault-tree approach suggested by the International Commission on Radiological Protection (IRCP) in its Publication 76. MATERIAL AND METHODS: Considering a typical radiotherapy installation we identified four possible staff irradiation scenarios, namely: 1) entry into the treatment room after a high-energy photon beam treatment, when induced radioactivity from photonuclear reactions has not decayed; 2) unintentional entry into the treatment room when the radiation beam is on; 3) beam failing to turn off at the end of treatment, and subsequent entry into the treatment room; 4) treatment room door inadvertently left ajar, and subsequent entry when the radiation beam is on. Each scenario depends on a particular set of parameters which are related to failure probabilities and workload. Average absorbed dose, exposure probability and related risk have been evaluated for each scenario. RESULTS: Under standard parameter set-up, the overall risk did not exceed the IRCP threshold (i.e., .0002) by more than four orders of magnitude. Two main sources of potential exposure have been identified, that is early entry into the treatment room before safe decay of activation products and unintentional entry during treatment. By varying the parameters within reasonable ranges, risk has been shown to correlate with personnel training, workload, installation characteristics and operational procedures. To optimize protection, quantitative limitations have been set for human error probability, daily workload, number and quality of safety devices and waiting time before entry after a treatment with high-energy radiations. CONCLUSIONS: Although the potential exposure risk for a typical radiotherapy department with standard safety devices is well below international recommended values, our results indicate that risk can be further decreased by improving personnel training, in particular relative to minimum time to entry after a high-energy treatment, to respecting warning signs and being skilled in emergency procedures. In addition, failing to install some safety devices or removing them after a failure may result in rapidly exceeding IRCP thresholds. 相似文献
143.
Increased frequency of euthyroid ophthalmopathy in patients with Graves' disease associated with myasthenia gravis. 总被引:3,自引:0,他引:3
M Marinò G Barbesino A Pinchera L Manetti R Ricciardi B Rossi A Muratorio L E Braverman S Mariotti L Chiovato 《Thyroid》2000,10(9):799-802
We previously showed that myasthenia gravis (MG) has a mild clinical expression when associated with autoimmune thyroid diseases (AITD). In the present study we have investigated the frequency of thyroid-associated ophthalmopathy (TAO) in patients with Graves' disease (GD) associated with MG as compared with GD patients without MG. A total of 418 patients with GD were studied, 31 with MG and 387 without MG. TAO was evaluated by physical examination, exophthalmometry, computerized tomography, and computerized visual fields assessment. The overall prevalence of TAO was similar in GD patients with MG (61.2%) and in those without MG (56.4%). When the analysis was restricted to GD patients with ocular MG, a greater frequency of TAO was found (84.6%), compared with GD patients without MG or with GD patients with generalized MG, although the differences did not reach the statistical significance. GD patients with MG had a significantly greater prevalence (12.9%) of euthyroid ophthalmopathy (clinically overt ophthalmopathy without previous and/or current hyperthyroidism) than those without MG (3.1%; p = 0.003). The results suggest a preferential association between the ocular manifestations of GD and MG, which may be due to immunological cross-reactivity against common autoimmune targets in the eye muscle as well as to a common genetic background. 相似文献
144.
Grazia Galli Francesco Annunziato Carmelo Mavilia Paola Romagnani Lorenzo Cosmi Roberto Manetti Cinzia Pupilli Enrico Maggi Sergio Romagnani 《European journal of immunology》1998,28(10):3280-3290
The human α-chemokine receptor fusin/CXCR4 is an important cofactor for entry of T lymphocyte-tropic HIV-1 strains. We investigated the possible regulatory role of T cell cytokine patterns on CXCR4 as well as HIV expression by using in vitro models of both secondary and primary immune responses. Antigen-specific memory CD4+ T cells infected with a T-tropic HIV-1 strain showed significantly higher CXCR4 and HIV-1 expression in Th0/2-oriented responses in comparison with Th1-oriented responses. Similarly, in naive CD4+ T cells activated in the presence of IL-4 or IL-12 and infected with the same T-tropic strain, IL-4 up-regulated whereas IL-12 down-regulated both CXCR4 and HIV-1 expression. The down-regulatory effect of IL-12 on CXCR4 expression was found to be dependent on its capacity to induce IFN-γ production. These observations can account for the higher risk of progression in HIV-1-infected individuals undergoing Th0/2-oriented immune responses. 相似文献
145.
Salvatore Marceddu Giulia Satta Valeria Papacciuoli Maria Antonia Pinna Alessandra Mela Giannina Secchi Grazia Galleri Roberto Manetti Luisa Bercich Vincenzo Villanacci Antonio Dessanti Roberto Antonucci Francesco Tanda Daniele Alberti Kathleen B. Schwarz Maria Grazia Clemente 《Hepatology research》2018,48(8):664-674
146.
147.
148.
Z Kibar S Salem CM Bosoi E Pauwels P De Marco E Merello AG Bassuk V Capra P Gros 《Clinical genetics》2011,80(1):76-82
Kibar Z, Salem S, Bosoi CM, Pauwels E, De Marco P, Merello E, Bassuk AG, Capra V, Gros P. Contribution of VANGL2 mutations to isolated neural tube defects. Vangl2 was identified as the gene defective in the Looptail (Lp) mouse model for neural tube defects (NTDs). This gene forms part of the planar cell polarity (PCP) pathway, also called the non‐canonical Frizzled/Dishevelled pathway, which mediates the morphogenetic process of convergent extension essential for proper gastrulation and neural tube formation in vertebrates. Genetic defects in PCP signaling have strongly been associated with NTDs in mouse models. To assess the role of VANGL2 in the complex etiology of NTDs in humans, we resequenced this gene in a large multi‐ethnic cohort of 673 familial and sporadic NTD patients, including 453 open spina bifida and 202 closed spinal NTD cases. Six novel rare missense mutations were identified in seven patients, five of which were affected with closed spinal NTDs. This suggests that VANGL2 mutations may predispose to NTDs in approximately 2.5% of closed spinal NTDs (5 in 202), at a frequency that is significantly different from that of 0.4% (2 in 453) detected in open spina bifida patients (p = 0.027). Our findings strongly implicate VANGL2 in the genetic causation of spinal NTDs in a subset of patients and provide additional evidence for a pathogenic role of PCP signaling in these malformations. 相似文献
149.
RAJ Windhaber AG Holbrook RJ Krysztopik 《Annals of the Royal College of Surgeons of England》2010,92(4):e10-e11
Chylothorax is a well-recognised complication of oesophagectomy, occurring in around 3% of cases. If managed conservatively, the mortality rate can be over 50%. We describe our experience of managing a patient with a chylothorax following oesophagectomy, and the use of a blood patch (a novel technique) to overcome persistent leakage following re-operation. The authors feel that this technique has the potential for a wider application in the treatment of chyle leak, especially if combined with minimally invasive or radiological techniques. 相似文献
150.